Update on Long-Term Efficacy and Safety of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, Over 5 Years from an Ongoing Phase 2 Open-Label Extension
| Autor: | Montalban, Xavier, Wolinsky, Jerry S., Arnold, Douglas L., Weber, Martin S., Piasecka-Stryczynska, Karolina, Starossom, Sarah C., Meier, Daniela Piani, Seitzinger, Andrea, Guehring, Hans, Tomic, Davorka |
|---|---|
| Zdroj: | In Multiple Sclerosis and Related Disorders December 2023 80 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect